FM
TWST icon

Freemont Management’s Twist Bioscience TWST Stock Holding History

Freemont Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-34,500
Closed -$1.22M – 134
2022
Q3 		$1.22M Buy
34,500
+4,500
+15% +$191K 0.22% 77
2022
Q2 		$1.05M Buy
+30,000
New +$1.06M 0.18% 86

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Freemont Management's TWST Position: Q4 2022 in Review

Freemont Management sold out of Twist Bioscience (TWST) in Q4 2022, closing a stake of 34,500 shares — an estimated $1.22M sold.

Freemont Management first reported a position in TWST in Q2 2022 and held it in 2 quarters. The position peaked at $1.22M in Q3 2022. 198 funds tracked by Wall St. Rank hold TWST as of Q4 2022.

  • Freemont Management reported no remaining Twist Bioscience position as of Q4 2022 after selling out during the quarter.
  • Freemont Management sold 34,500 Twist Bioscience shares in Q4 2022, an estimated $1.22M.
  • Freemont Management first reported a position in Twist Bioscience in Q2 2022 and held it in 2 quarters.
  • Freemont Management's Twist Bioscience position peaked at $1.22M in Q3 2022.
  • 198 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2022.

Based on Freemont Management's 13F filing for Q4 2022, filed 10 Feb 2023.